The potential role of ventricular compressive therapy
Congestive heart failure (CHF) affects 4.7 million Americans [1]. Intense basic and clinical
research over the past 30 years has increased our understanding of the disease and led to
new treatments. The clinical impact of these strategies has, however, been disappointing.
Five-year mortality remains at least 50%[2]. Although early recognition and improved
therapy for hypertension and valvular heart disease have tended to reduce the incidence of
CHF, these improvements have been overwhelmed by a dramatic increase in the incidence …
research over the past 30 years has increased our understanding of the disease and led to
new treatments. The clinical impact of these strategies has, however, been disappointing.
Five-year mortality remains at least 50%[2]. Although early recognition and improved
therapy for hypertension and valvular heart disease have tended to reduce the incidence of
CHF, these improvements have been overwhelmed by a dramatic increase in the incidence …